US Adds Merck Pill as 2nd Easy-To-Use Drug Against COVID-19

An illustration of COVID-19 by the Centers for Disease Control and Prevention.

WASHINGTON (AP) – U.S. regulators have authorized a second pill against COVID-19, an antiviral drug from Merck that may help blunt the wave of infections driven by the omicron variant.

The Food and Drug Administration granted the drug emergency use Thursday for adults with early COVID-19 who face the highest risks of hospitalization.

It comes after the FDA greenlighted a more effective pill from Pfizer. As a result, Merck’s drug may play have a far smaller role than initially predicted.

Final study results show Merck’s drug is much less effective than originally predicted. And the drug will carry strict safety warnings due to the risk of birth defects when used during pregnancy.

By Matthew Perrone, Associated Press

About Brendan Fitzpatrick

Brendan, a recent graduate from the University of Massachusetts Amherst, is one of the newest members of the NewsCenter team. When not on the beat, you'll probably find him watching Boston sports.
737 West Main Street
Hyannis, MA 02601
Contact Us | Advertise Terms of Use 
Employment and EEO | Privacy